Buscar
Kamada Ltd
KMDAAñadir a la lista de seguimiento
7.500USD
-0.020-0.27%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
432.65MCap. mercado
21.41P/E TTM
Más Datos de Kamada Ltd Compañía
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Información de Kamada Ltd
Símbolo de cotizaciónKMDA
Nombre de la empresaKamada Ltd
Fecha de salida a bolsaAug 01, 2005
Director ejecutivoLondon (Amir)
Número de empleados374
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 01
Dirección2 Holtzman St., Science Park
CiudadREHOVOT
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal7670402
Teléfono97289406472
Sitio Webhttps://www.kamada.com/
Símbolo de cotizaciónKMDA
Fecha de salida a bolsaAug 01, 2005
Director ejecutivoLondon (Amir)
Ejecutivos de Kamada Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
--
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Dr. Ruth Wolfson
Dr. Ruth Wolfson
Senior Vice President - Scientific Affairs
Senior Vice President - Scientific Affairs
--
--
Ms. Pnina Strauss
Ms. Pnina Strauss
Vice President - Inhalation programs & IP
Vice President - Inhalation programs & IP
--
--
Mr. Tuvia Shoham
Mr. Tuvia Shoham
Independent Director
Independent Director
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
DR. Naveh Tov
DR. Naveh Tov
Vice President-Clinical Development and Medical
Director for Pulmonary Diseases
Vice President-Clinical Development and Medical
Director for Pulmonary Diseases
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
--
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Dr. Ruth Wolfson
Dr. Ruth Wolfson
Senior Vice President - Scientific Affairs
Senior Vice President - Scientific Affairs
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Kamada Ltd?
Los cinco principales accionistas de Kamada Ltd son: Mr. Leon Yehuda Recanati
¿Cuántas instituciones poseen acciones de Kamada Ltd (KMDA)?
A fecha de 2026Q1, 98 instituciones poseen acciones de Kamada Ltd, con un valor de mercado combinado de aproximadamente 28.17M, lo que representa el 48.83% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -2157241.00.